person · Reporting owner
Yang Watkin Phoebe L.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Doximity, Inc.DOCS · Entity 1570 | Director | September 30, 2026 | October 03, 2026 |
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | Director | May 07, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Doximity, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 24,744 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Sale · Disposed 1,290 · Balance 24,744 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.
GE HealthCare Technologies Inc.
Report date May 07, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 13,702 |
Ending reported balance
After 2026-05-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-07 · Grant · Acquired 3,586 · Balance 12,702 F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Row 2 · 2026-05-08 · Purchase · Acquired 1,000 · Balance 13,702 F3: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:09 UTC | Doximity, Inc. DOCS · Entity 1570 | SaleClass A Common Stock | 1,290 | $26.71 | $34,455.90 |
DisclosureSEC source: 0001470831-26-000921 · wk-form4_1790971777.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,744 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:42 UTC | Doximity, Inc. DOCS · Entity 1570 | GrantClass A Common Stock | 8,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000861 · wk-form4_1788208969.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,034 F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on August 27, 2026 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 08, 2026 Filed May 12, 2026 00:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | PurchaseCommon Stock, par value $0.01 per share | 1,000 | $63.01 | $63,006.30 |
DisclosureSEC source: 0001940538-26-000002 · wk-form4_1778544964.xml · nonDerivative · entry 2 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,702 F3 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001940538-26-000002 · wk-form4_1778544964.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,702 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| August 28, 2025 Filed Sep 2, 2025 23:24 UTC | Doximity, Inc. DOCS · Entity 1570 | GrantClass A Common Stock | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000164 · wk-form4_1756855472.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,950 F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on August 28, 2025 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:42 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028683 · wk-form4_1748641313.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,116 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:08 UTC | Doximity, Inc. DOCS · Entity 1570 | SaleClass A Common Stock | 2,889 | $75.19 | $217,209.47 |
DisclosureSEC source: 0001516513-25-000026 · wk-form4_1739480886.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,729 Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 20:09 UTC | Doximity, Inc. DOCS · Entity 1570 | GrantClass A Common Stock | 6,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001516513-24-000084 · wk-form4_1725048583.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,618 F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on August 29, 2024 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 20:35 UTC | Doximity, Inc. DOCS · Entity 1570 | SaleClass A Common Stock | 1,011 | $25.54 | $25,820.94 |
DisclosureSEC source: 0001516513-24-000057 · wk-form4_1722976518.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,258 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2023. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 20:01 UTC | Doximity, Inc. DOCS · Entity 1570 | SaleClass A Common Stock | 1,940 | $28.22 | $54,746.80 |
DisclosureSEC source: 0001516513-24-000053 · wk-form4_1722456065.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,269 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2023. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:35 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024975 · wk-form4_1716496489.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:38 UTC | Doximity, Inc. DOCS · Entity 1570 | GrantClass A Common Stock | 5,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001516513-23-000057 · wf-form4_169057672108659.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,209 F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on July 26, 2023 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:28 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019774 · wf-form4_168504649835345.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 21:55 UTC | Doximity, Inc. DOCS · Entity 1570 | GrantClass A Common Stock | 8,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001516513-22-000073 · wf-form4_165965011628593.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,665 F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on August 2, 2022 pursuant to the Issuer's non-employee director compensation policy, which vest in equal annual installments over three years on each anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.